These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 15203266

  • 1. Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patients.
    Blich M, Gross B.
    Int J Cardiol; 2004 Jul; 96(1):89-95. PubMed ID: 15203266
    [Abstract] [Full Text] [Related]

  • 2. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S, Trappolini M, Chillotti FM.
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [Abstract] [Full Text] [Related]

  • 3. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R, Lazzerini G, Cocci F, De Caterina R.
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [Abstract] [Full Text] [Related]

  • 4. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL, SPORTIF Investigators.
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 6. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH, Park JS, Park JH, Park JS, Kwak JJ, Hwang ES, Kim SK, Choi DH, Kim YH, Pak HN.
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [Abstract] [Full Text] [Related]

  • 7. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T, Maillard L, Mas JL, Mentré F, Pousset F, Lacomblez L, Pisica G, Solbes-Latourette S, Raynaud P, Chaumet-Riffaud P, Investigateurs de FFAACS.
    Therapie; 2000 May; 55(6):681-9. PubMed ID: 11234463
    [Abstract] [Full Text] [Related]

  • 8. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators.
    J Am Coll Cardiol; 2007 Nov 27; 50(22):2156-61. PubMed ID: 18036454
    [Abstract] [Full Text] [Related]

  • 9. [Atrial fibrillation and thromboembolism: a multicenter cooperative study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 1998 Apr 27; 31(4):227-38. PubMed ID: 9594372
    [Abstract] [Full Text] [Related]

  • 10. Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
    Lopes RD, Alexander JH, Al-Khatib SM, Ansell J, Diaz R, Easton JD, Gersh BJ, Granger CB, Hanna M, Horowitz J, Hylek EM, McMurray JJ, Verheugt FW, Wallentin L, ARISTOTLE Investigators.
    Am Heart J; 2010 Mar 27; 159(3):331-9. PubMed ID: 20211292
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR, Stevenson WG, Gornbein JA.
    Arch Intern Med; 1995 May 08; 155(9):913-20. PubMed ID: 7726699
    [Abstract] [Full Text] [Related]

  • 12. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.
    Pharmacotherapy; 2007 May 08; 27(5):691-6. PubMed ID: 17461704
    [Abstract] [Full Text] [Related]

  • 13. A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).
    Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS.
    Age Ageing; 2007 Mar 08; 36(2):151-6. PubMed ID: 17175564
    [Abstract] [Full Text] [Related]

  • 14. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H, Willems S, Hindricks G, Chen X, Haverkamp W, Hasfeld M, Borggrefe M, Breithardt G.
    Z Kardiol; 1993 Nov 08; 82(11):667-73. PubMed ID: 8291287
    [Abstract] [Full Text] [Related]

  • 15. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: Rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V).
    Halperin JL, Executive Steering Committee, SPORTIF III and V Study Investigators.
    Am Heart J; 2003 Sep 08; 146(3):431-8. PubMed ID: 12947359
    [Abstract] [Full Text] [Related]

  • 16. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM, Marín F, Hurtado JA, Valencia J, Pinar E, Pineda J, Gimeno JR, Sogorb F, Valdés M, Lip GY.
    J Am Coll Cardiol; 2008 Feb 26; 51(8):818-25. PubMed ID: 18294566
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors for thromboembolism in patients with atrial fibrillation during treatment with aspirin: a multicenter, cooperative retrospective study. Research Group for Antiarrhythmic Drug Therapy].
    J Cardiol; 2000 May 26; 35(5):373-9. PubMed ID: 10834181
    [Abstract] [Full Text] [Related]

  • 18. Thromboembolic events occur despite sinus rhythm maintenance in patients treated for atrial fibrillation: The Canadian Trial of Atrial Fibrillation experience.
    Thibault B, Talajic M, Dubuc M, Guerra P, Gagné P, Roy D, Connolly S, Canadian Trial of Atrial Fibrillation.
    Can J Cardiol; 2004 Feb 26; 20(2):195-9. PubMed ID: 15010743
    [Abstract] [Full Text] [Related]

  • 19. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR, Naimark DM, Oliver MJ, Bayoumi AM.
    Am J Kidney Dis; 2007 Sep 26; 50(3):421-32. PubMed ID: 17720521
    [Abstract] [Full Text] [Related]

  • 20. Antithrombotic therapy in atrial fibrillation.
    Turpie AG, Connolly SJ.
    Can Fam Physician; 1996 Jul 26; 42():1341-5. PubMed ID: 8754703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.